Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 101, Issue 4-5, 2006, Pages 216-225

  Rice, Suman ^a   Mason, Helen D ^a   Whitehead, Saffron A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Aromatase; mRNA expression; Oestradiol; Phytoestrogens

Indexed keywords

APIGENIN; AROMATASE; BIOCHANIN A; DAIDZEIN; ESTRADIOL; FLAVONE DERIVATIVE; GENISTEIN; ISOFLAVONE DERIVATIVE; MESSENGER RNA; PHYTOESTROGEN; QUERCETIN; TESTOSTERONE;

ARTICLE; CELL CULTURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GRANULOSA CELL; HUMAN; HUMAN CELL; LOW DRUG DOSE; LUTEAL CELL; PHARMACODYNAMICS; PHARMACOGENETICS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AROMATASE; CELLS, CULTURED; DOWN-REGULATION; DRUG INTERACTIONS; FEMALE; FLAVONES; HUMANS; ISOFLAVONES; LUTEAL CELLS; ORGANIC CHEMICALS; PHYTOESTROGENS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33750132434     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.06.021     Document Type: Article

References (55)

1. Kuiper G.G., Lemmen J.G., Carlssson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139 (1998) 4252-5263
2. Adlercreutz H., Bannwart C., Wähàlä T., Makeal T., Brunow G., Hase T., Arosemena P.J., Kellis Jr. T.J., and Vickery L.E. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J. Steriod. Biochem. Mol. Biol. 44 (1993) 147-153
3. Le Bail J.C., Champavier Y., Chulia A.J., and Habrioux G. Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase and human breast cancer cells. Life Sci. 66 (2000) 1281-1291
4. Lacey M., Bohday J., Shamara M.R., Ullah A.I., and Whitehead S.A. Dose-response effects of phytoestrogens on the activity and expression of 3β-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells. J. Steroid Biochem. Mol. Biol. 96 (2005) 279-286
5. Deluca D., Krazeisen A., Breitling R., Prehn C., Moller G., and Adamski J. Inhibition of 17beta-hydroxysteroid dehydrogenases by phytoestrogens: comparison with other steroid metabolizing enzymes. J. Steroid Biochem. Mol. Biol. 93 (2005) 285-292
6. Whitehead S.A., and Rice S. Endocrine disrupting chemicals as modulators of sex steroid synthesis. Best Practice & Res. Clin. Endocrinol. Metab. 20 (2006) 45-61
7. Brooks J.D., and Thompson L.U. Mammalian lignans and genistein decrease the activities of aromatase and 17β-hyroxysteriod dehydrogenase in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 94 (2005) 461-467
8. Krazeisen A., Breitling R., Möller G., and Adamski J. Phytoestrogens inhibit human 17β-hydroxysteroid dehydrogenase type 5. Mol. Cell Endocrinol. 171 (2001) 151-162
9. Whitehead S.A., and Lacey M. Phytoestrogens inhibit aromatase but not 17β-hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa-luteal cells; evidence for FSH induction of 17β-HSD. Hum. Reprod. 18 (2003) 487-494
10. Ohno S., Matsukmoto N., Watanade M., and Nakajin S. Flavonoid inhibition of overexpressed human 3β-hydroxysteroid dehydrogenase type II. J. Steroid Biochem. Mol. Biol. 88 (2004) 175-182
11. Howell A., and Wardley A.M. Overview of the impact of conventional systemic therapies on breast cancer. Endocr. Rel. Cancer 12 Suppl. 1 (2005) S9-S16
12. Limer J.L., and Speirs V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res. 6 (2004) 119-127
13. Wang C., Mäkelä T., Hase T., Adlercreutz H., and Kurzer M.S. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J. Steriod Biochem. Mol. Biol. 50 (1994) 205-215
14. M.W. Pfaffl, Quantification strategies in real-time PCR, Chapter 3, Bustin SA, International University Line, La Jolla, CA, USA, 2004.
15. Bustin S.A., and Nolan T. Pitfalls of quantitative real-time RT-PCR. J. Biomol. Tech. 15 (2004) 155-166
16. - Δ Δ Ct method. Methods 25 (2001) 402-408
17. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res. 29 9 (2001) e45
18. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucl. Acids Res. 30 9 (2002) e36-e45
19. Pfaffl M.W., Tichopad A., Prgomet C., and Neuvians T.P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol. Lett. 26 6 (2004) 509-515
20. Kellis J.T., and Vickery L.E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 225 (1984) 1032-1034
21. Le Bail J.C., Laroche T., Marre-Fournier F., and Habrioux G. Aromatase and 17β-hydroxysteriod dehydrogenase inhibition by flavonoids. Cancer Lett. 133 (1998) 101-110
22. Jeong H.J., Shin Y.G., Kim I.H., and Pezzuto J.M. Inhibition of aromatase activity by flavones. Arch. Pharm. Res. 22 (1999) 309-312
23. Brueggemeier R.W., Gu X., Mobley J.A., Joomprabutra S., Bhat A.S., and Whetstone J.L. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis and metabolism. Ann. N Y Acad. Sci. 948 (2001) 51-66
24. Almstrup K., Fernández M.F., Petersen J.H., Olea N., Skakkebaek N.E., and Leffers H. Dual effects of phytoestrogen result in U-shaped dose-response curves. Environ. Health Perspect. 110 (2002) 743-748
25. Sanderson J.T., Hordijk J., Denison M.S., Springsteel M.F., Nantz M.H., and van den Berg M. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic favonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol. Sci. 82 (2004) 70-79
26. Myllymäki S., Haavisto T., Vainio M., Toppari J., and Pranko J. In vitro effects of diethylstilbestrol, genistein, 4-tert-butylphenol, and 4-tert-octylphenol on steroidogenic activity of isolated immature rat ovarian follicles. Toxicol. Appl. Pharmacol. 204 (2005) 69-80
27. Kao Y.-C., Zhou C., Sherman M., Laughton C.A., and Chen S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site directed mutagenesis study. Environ. Health Perspect. 106 (1998) 895-992
28. Mazur W., and Adlercreutz H. Overview of naturally occurring endocrine-active substances in the human diet in relation to human health. Nutrition 16 (2000) 654-687
29. Campbell D.R., and Kurzer M.S. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J. Steroid Biochem. Mol. Biol. 46 (1993) 381-388
30. Hanukoglu I. Steroidogenic enzymes: structure function and role in regulation of steroid hormone biosyntheis. J. Steroid Biochem. Mol. Biol. 43 (1992) 779-804
31. Genissel C., Levallet J., and Carreau S. Regulation of cytochrome P450 aromatase gene expression in adult rat Leydig cells: comparison with esradiol production. Endocrinology 168 (2001) 95-105
32. Mu Y.-M., Yanase T., Nishi Y., Takayanagi R., Goto K., and Nawata H. Combined treatment with specific ligands for PPARγ: RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Mol. Cell Endocrinol. 181 (2001) 239-248
33. Couse J.F., Yates M.M., Deroo B.J., and Korach K.S. Estrogen receptor-beta is critical to granulosa cell differentiation and the ovulatory response to gonadotropins. Endocrinology 146 (2005) 3244-3246
34. Emmen J.M., Couse J.F., Elmore S.A., Yates M.M., Kissling G.E., and Korach K.S. In vitro growth and ovulation of follicles from ovaries of estrogen receptor (ER) {alpha} and ER {beta} null mice indicate a role for Er {beta} in follicular maturation. Endocrinology 146 (2005) 2817-2826
35. Walker V.R., and Korach K.S. Estrogen receptor knockout mice as a model for endocrine research. ILAR J 45 (2004) 455-461
36. Costrici N., Lunenfeld B., Pariente C., Dor J., Rabinovici J., Kanety H., and Karasik A. Induction of aromatase in human granulosa cells by both follicle stimulating hormone and insulin-like growth factor-I involves tyrosine phosphorylation. Gynaecol. Endocrinol. 8 (1994) 183-189
37. Whitehead S.A., and Lacey M. Protein tyroxine kinase activity of lavendustin A and the phytoestrogen genistein on progesterone synthesis in cultured rat ovarian cells. Fertil. Steril. 73 (2000) 613-619
38. Burns K.H., Yan C., Kumar T.R., and Matzuk M.M. Analysis of ovarian gene expression in follicle-stimulating hormone beta knockout mice. Endocrinology 142 (2001) 2742-2751
39. Yu F.Q., Han C.S., Yang W., Jin X., Hu Z.Y., and Liu Y.X. Activation of the p38 MAPK pathway by follicle-stimulating hormone regulates steroidogenesis in granulosa cells differentially. J. Endocrinol. 186 (2005) 85-96
40. McDonald C.A., Millena A.C., Reddy S., Finlay S., Vizcarra J., Khan S.A., and Davis J.S. Follicle-stimulating hormone-induced aromatase in immature rat Sertoli cells requires an active phosphatidylinositol 3-kinase pathway and is inhibited via the mitogen-activated protein kinase signalling pathway. Mol. Endocrinol. 20 (2006) 608-618
41. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., and Fukami Y. Genistein, a specific inhibitor of tyroxine-specific protein kinases. J. Biol. Chem. 262 (1987) 5592-5595
42. Gamet-Payrastre L., Manenti S., Gratacap M.P., Tulliez J., Chap H., and Payrastre B. Flavinoids and the inhibition of PKC and PI3-kinase. Gen. Pharmacol. 32 (1999) 279-286
43. Yin F., Giuliano A.E., Law R.E., and Van Herle A.J. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res. 21 (2001) 413-420
44. Nguyen T.T.T., Tran E., Nguyen T.H., Do P.T., Huynh T.H., and Huynh H. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung. Carcinogenesis 5 (2004) 647-659
45. Menuet A., Pellegrini E., Brion F., Gueguen M.M., Anglade I., Pakdel F., and Kah O. Expression and estrogen-dependent regulation of the zebrafish brain aromatase gene. J. Comp. Neurol. 16 (2005) 304-320
46. 450 aromatase expressions in human preadipocytes: sex specificities. J. Steroid Biochem. Mol. Biol. 99 (2006) 189-196
47. Yang C., Yu B., Zhou D., and Chen S. Regulation of aromatase promoter activity in human breast tissue by nuclear receptors. Oncogene 18 (2002) 2854-2863
48. Mu Y.M., Yanase T., Nishi Y., Takayanagi R., Goto K., and Nawata H. Combined treatment with specific ligands for PPARgamma: RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Mol. Cell Endocrinol. 181 (2001) 239-248
49. Shupnik M.A. Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene 23 (2004) 7979-7989
50. 1. Cancer Res. 63 (2003) 3546-3555
51. Trisomboon H., Malaivijitnond S., Watanabe G., and Taya K. Estrogenic effects of pueraria mirifica on the menstrual cycle and hormone-related ovarian functions in cyclic female cynomolgus monkeys. J. Pharmacol. Sci. 94 (2004) 51-59
52. Cassidy A., Bingham S., and Setchell K.D.R. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br. J. Nutr. 74 (1995) 587-601
53. Shimizu H., Ross R.K., Bernstein L., Pike M.C., and Henderson B.E. Serum oestrogen levels in postmenopausal women: comparision of American whites and Japanese in Japan. Br. J. Cancer 62 (1990) 451-453
54. Nagata C., Takatsuka N., Inaba S., Kawakami N., and Shimizu H. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J. Natl. Cancer Inst. 90 (1998) 1830-1835
55. Adlercreutz H. The epidemiology of phytoestrogens. Baillière's Clin. Endocrinol. Metab. 4 (1998) 605-623